Cargando…

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified Vaccinia virus Ankara (MVA)

Camelpox is a viral contagious disease of Old-World camelids sustained by Camelpox virus (CMLV). The disease is characterized by mild, local skin or severe systemic infections and may have a major economic impact due to significant losses in terms of morbidity and mortality, weight loss, and low mil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcacci, Maurilia, Khalafalla, Abdelmalik I., Al Hammadi, Zulaikha M., Monaco, Federica, Cammà, Cesare, Yusof, Mohammed F., Al Yammahi, Saeed M., Mangone, Iolanda, Valleriani, Fabrizia, Alhosani, Mohamed A., Decaro, Nicola, Lorusso, Alessio, Almuhairi, Salama S., Savini, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472314/ https://www.ncbi.nlm.nih.gov/pubmed/32717784 http://dx.doi.org/10.3390/v12080786

Ejemplares similares

More cell culture passaged Camelpox virus sequences found resembling those of vaccinia virus
por: Khalafalla, Abdelmalik I., et al.
Publicado: (2020)

Complete Genome Sequence of Bluetongue Virus Serotype 1 Circulating in Italy, Obtained through a Fast Next-Generation Sequencing Protocol
por: Lorusso, Alessio, et al.
Publicado: (2014)

Complete Genome Sequence Analysis of a Reassortant Strain of Bluetongue Virus Serotype 16 from Italy
por: Lorusso, Alessio, et al.
Publicado: (2013)

Genome characterization of feline morbillivirus from Italy
por: Marcacci, Maurilia, et al.
Publicado: (2016)

Isolation and genetic characterization of MERS-CoV from dromedary camels in the United Arab Emirates
por: Khalafalla, Abdelmalik Ibrahim, et al.
Publicado: (2023)

Diagnosis and characterization of canine distemper virus through sequencing by MinION nanopore technology
por: Peserico, Alessia, et al.
Publicado: (2019)

Development of an Inactivated Camelpox Vaccine from Attenuated Camelpox Virus Strain: Safety and Protection in Camels
por: Zhugunissov, Kuandyk, et al.
Publicado: (2023)

A Genotype of Modified Vaccinia Ankara (MVA) that Facilitates Replication in Suspension Cultures in Chemically Defined Medium
por: Jordan, Ingo, et al.
Publicado: (2013)

Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
por: Goossens, Martine, et al.
Publicado: (2013)

Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)
por: Klaas, Lioba, et al.
Publicado: (2021)

Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
por: Cottingham, Matthew G., et al.
Publicado: (2008)

Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE(®) against aerosolized rabbitpox virus in a rabbit model()
por: Garza, Nicole L., et al.
Publicado: (2009)

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
por: Altenburg, Arwen F., et al.
Publicado: (2014)

Epidemiological and genomic findings of the first documented Italian outbreak of SARS-CoV-2 Alpha variant of concern
por: Amato, Laura, et al.
Publicado: (2022)

Characterization and In Vitro Efficacy against Listeria monocytogenes of a Newly Isolated Bacteriophage, ΦIZSAM-1
por: Scattolini, Silvia, et al.
Publicado: (2021)

First Diagnosed Case of Camelpox Virus in Israel
por: Erster, Oran, et al.
Publicado: (2018)

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
por: Shen, Xiaoying, et al.
Publicado: (2017)

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
por: Cottingham, Matthew G., et al.
Publicado: (2011)

Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Nave, Lior, et al.
Publicado: (2023)

Molecular Investigation on Tick-Borne Hemoparasites and Coxiella burnetii in Dromedary Camels (Camelus dromedarius) in Al Dhafra Region of Abu Dhabi, UAE
por: El Tigani-Asil, El Tigani Ahmed, et al.
Publicado: (2021)

SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species
por: Di Teodoro, Giovanni, et al.
Publicado: (2021)

Draft Genome Sequences of 19 Salmonella enterica Serovar Typhimurium [4,5:i:−] Strains Resistant to Nalidixic Acid from a Long-Term Outbreak in Italy
por: Orsini, Massimiliano, et al.
Publicado: (2015)

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
por: Frey, Sharon E., et al.
Publicado: (2015)

Study of Camelpox Virus Pathogenesis in Athymic Nude Mice
por: Duraffour, Sophie, et al.
Publicado: (2011)

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)
por: Chiam, Rachael, et al.
Publicado: (2009)

Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells
por: Peng, Chen, et al.
Publicado: (2020)

Whole-Genome Sequence of a Suid Herpesvirus-1 Strain Isolated from the Brain of a Hunting Dog in Italy
por: Pizzurro, Federica, et al.
Publicado: (2016)

Evaluation of next generation sequencing approaches for SARS-CoV-2
por: Curini, Valentina, et al.
Publicado: (2023)

A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy
por: Lorusso, Alessio, et al.
Publicado: (2020)

Early viral protein synthesis is necessary for NF-κB activation in modified vaccinia Ankara (MVA)-infected 293 T fibroblast cells
por: Martin, Stefani, et al.
Publicado: (2009)

Recombinant Modified Vaccinia Virus Ankara (MVA) Expressing Wild-Type Human p53 Induces Specific Antitumor CTL Expansion
por: Song, Guang-Yun, et al.
Publicado: (2011)

Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
por: Currier, Jeffrey R., et al.
Publicado: (2010)

The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
por: Volkmann, Ariane, et al.
Publicado: (2021)

Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccines Efficiently Protect Cockatiels Against Parrot Bornavirus Infection and Proventricular Dilatation Disease
por: Rall, Isabell, et al.
Publicado: (2019)

A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA)
por: Jordan, Ingo, et al.
Publicado: (2019)

Comparison of Microscopy, Card Agglutination Test for Trypanosoma Evansi, and Real-time PCR in The Diagnosis of Trypanosomosis in Dromedary Camels of The Abu Dhabi Emirate, UAE
por: Habeeba, Shameem, et al.
Publicado: (2022)

Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
por: Delaloye, Julie, et al.
Publicado: (2009)

SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells
por: Liu, Ruikang, et al.
Publicado: (2019)

SARS-CoV-2 surveillance in Italy through phylogenomic inferences based on Hamming distances derived from pan-SNPs, -MNPs and -InDels
por: Di Pasquale, Adriano, et al.
Publicado: (2021)

Complete Genome Sequence of the First Camelpox Virus Case Diagnosed in Israel
por: Israeli, Ofir, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pofgopsqevbdjo96qdhcke5cfk